BeiGene files amended form 10-K, correcting signature omission

BeiGene (HKEX:6160) announced the filing of Amendment No. 1 to its Form 10-K for the year ended December 31, 2024. The amendment, filed with the U.S. Securities and Exchange Commission on February 28, 2025, was made solely to include the conformed signature of the company's principal accounting officer, Titus Ball, which was inadvertently omitted from the original filing. The company confirms that no other changes were made to the original Form 10-K and that the amendment does not reflect any events occurring after the initial filing date. The filing includes certifications from the CEO John V. Oyler and CFO Aaron Rosenberg.